6 results on '"Machicote, Andres"'
Search Results
2. Enabling X-ray fluorescence imaging for in vivo immune cell tracking.
- Author
-
Staufer, Theresa, Körnig, Christian, Liu, Beibei, Liu, Yang, Lanzloth, Clarissa, Schmutzler, Oliver, Bedke, Tanja, Machicote, Andres, Parak, Wolfgang J., Feliu, Neus, Bosurgi, Lidia, Huber, Samuel, and Grüner, Florian
- Subjects
- *
X-ray fluorescence , *X-ray imaging , *MULTIPLE scattering (Physics) , *COMPTON scattering , *X-rays - Abstract
The infiltration of immune cells into sites of inflammation is one key feature of immune mediated inflammatory diseases. A detailed assessment of the in vivo dynamics of relevant cell subtypes could booster the understanding of this disease and the development of novel therapies. We show in detail how advanced X-ray fluorescence imaging enables such quantitative in vivo cell tracking, offering solutions that could pave the way beyond what other imaging modalities provide today. The key for this achievement is a detailed study of the spectral background contribution from multiple Compton scattering in a mouse-scaled object when this is scanned with a monochromatic pencil X-ray beam from a synchrotron. Under optimal conditions, the detection sensitivity is sufficient for detecting local accumulations of the labelled immune cells, hence providing experimental demonstration of in vivo immune cell tracking in mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Characterization of a new subset of CD8+HLA-DR+ T cells in human decidua.
- Author
-
Machicote, Andres P., Podhorzer, Ariel, Tolosa, Eva, Arck, Petra C., Solano, Maria E., and Fainboim, Leonardo
- Subjects
- *
HLA histocompatibility antigens , *CD8 antigen , *T cell differentiation , *DECIDUA , *REPRODUCTIVE immunology , *TRYPTOPHAN - Published
- 2016
- Full Text
- View/download PDF
4. CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis.
- Author
-
Zhang, Tao, Wahib, Ramez, Zazara, Dimitra E., Lücke, Jöran, Shiri, Ahmad Mustafa, Kempski, Jan, Zhao, Lilan, Agalioti, Theodora, Machicote, Andres Pablo, Giannou, Olympia, Belios, Ioannis, Jia, Rongrong, Zhang, Siwen, Tintelnot, Joseph, Seese, Hannes, Grass, Julia Kristin, Mercanoglu, Baris, Stern, Louisa, Scognamiglio, Pasquale, and Fard-Aghaie, Mohammad
- Subjects
- *
LIVER metastasis , *CD4 antigen , *NEOVASCULARIZATION , *T cells , *CANCER cells - Abstract
Metastasis is a cancer-related systemic disease and is responsible for the greatest mortality rate among cancer patients. Interestingly, the interaction between the immune system and cancer cells seems to play a key role in metastasis formation in the target organ. However, this complex network is only partially understood. We previously found that IL-22 produced by tissue resident iNKT17 cells promotes cancer cell extravasation, the early step of metastasis. Based on these data, we aimed here to decipher the role of IL-22 in the last step of metastasis formation. We found that IL-22 levels were increased in established metastatic sites in both human and mouse. We also found that Th22 cells were the key source of IL-22 in established metastasis sites, and that deletion of IL-22 in CD4+ T cells was protective in liver metastasis formation. Accordingly, the administration of a murine IL-22 neutralizing antibody in the establishment of metastasis formation significantly reduced the metastatic burden in a mouse model. Mechanistically, IL-22-producing Th22 cells promoted angiogenesis in established metastasis sites. In conclusion, our findings highlight that IL-22 is equally as important in contributing to metastasis formation at late metastatic stages, and thus, identify it as a novel therapeutic target in established metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma.
- Author
-
Giannou, Anastasios D., Lücke, Jöran, Kleinschmidt, Dörte, Shiri, Ahmad Mustafa, Steglich, Babett, Nawrocki, Mikolaj, Zhang, Tao, Zazara, Dimitra E., Kempski, Jan, Zhao, Lilan, Giannou, Olympia, Agalioti, Theodora, Brockmann, Leonie, Bertram, Franziska, Sabihi, Morsal, Böttcher, Marius, Ewald, Florian, Schulze, Kornelius, von Felden, Johann, and Machicote, Andres
- Subjects
- *
INTERLEUKINS , *ANIMAL experimentation , *ONCOGENES , *NEUTROPHILS , *LIVER cells , *CARRIER proteins , *HEPATOCELLULAR carcinoma , *MICE - Abstract
Simple Summary: Hepatocellular carcinoma (HCC) still poses a major challenge for curative treatment. Although some new therapeutic options arose during the last decade, the overall prognosis remains poor. New therapies might include the modification of tumor-promoting or -inhibiting mediators of the immune system, such as interleukin (IL)-22 and its natural antagonist IL-22 binding protein (IL-22BP). Thus, this study aimed to investigate the role and underlying mechanisms of IL-22 and IL-22BP signaling in liver cancer. Using two different mouse models, we found that IL-22 promoted HCC development, while IL-22BP led to reduced tumor growth. IL-22 was mainly produced by a subset of T cells in HCC, whereas IL-22BP was abundantly secreted by neutrophils. Importantly, we identified hepatocytes as a major target of this pathological IL-22-signaling. Moreover, abrogation of IL-22 signaling in hepatocytes reduced STEAP4 expression-a known oncogene-in an HCC mouse model in vivo, and STEAP4 expression correlated with IL22 levels in human HCC samples. Taken together, these data might pave the way for new therapeutical approaches by blocking IL-22 or its downstream signaling in HCC. Hepatocellular carcinoma (HCC) ranks among the five most common cancer entities worldwide and leads to hundred-thousands of deaths every year. Despite some groundbreaking therapeutical revelations during the last years, the overall prognosis remains poor. Although the immune system fights malignant transformations with a robust anti-tumor response, certain immune mediators have also been shown to promote cancer development. For example, interleukin (IL)-22 has been associated with HCC progression and worsened prognosis in multiple studies. However, the underlying mechanisms of the pathological role of IL-22-signaling as well as the role of its natural antagonist IL-22 binding protein (IL-22BP) in HCC remain elusive. Here, we corroborate the pathogenic role of IL-22 in HCC by taking advantage of two mouse models. Moreover, we observed a protective role of IL-22BP during liver carcinogenesis. While IL-22 was mainly produced by CD4+ T cells in HCC, IL-22BP was abundantly expressed by neutrophils during liver carcinogenesis. Hepatocytes could be identified as a major target of this pathological IL-22-signaling. Moreover, abrogation of IL-22 signaling in hepatocytes in IL22ra1flox/flox × AlbCre+ mice reduced STEAP4 expression-a known oncogene-in HCC in vivo. Likewise, STEAP4 expression correlated with IL22 levels in human HCC samples, but not in healthy liver specimens. In conclusion, these data encourage the development of therapeutical approaches that target the IL-22–IL-22BP axis in HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. In-situ x-ray fluorescence imaging of the endogenous iodine distribution in murine thyroids.
- Author
-
Körnig, Christian, Staufer, Theresa, Schmutzler, Oliver, Bedke, Tanja, Machicote, Andres, Liu, Beibei, Liu, Yang, Gargioni, Elisabetta, Feliu, Neus, Parak, Wolfgang J., Huber, Samuel, and Grüner, Florian
- Subjects
- *
X-ray imaging , *MULTIPLE scattering (Physics) , *COMPTON scattering , *IODINE , *X-ray spectra - Abstract
X-ray fluorescence imaging (XFI) is a non-invasive detection method of small quantities of elements, which can be excited to emit fluorescence x-ray photons upon irradiation with an incident x-ray beam. In particular, it can be used to measure nanoparticle uptake in cells and tissue, thus making it a versatile medical imaging modality. However, due to substantially increased multiple Compton scattering background in the measured x-ray spectra, its sensitivity severely decreases for thicker objects, so far limiting its applicability for tracking very small quantities under in-vivo conditions. Reducing the detection limit would enable the ability to track labeled cells, promising new insights into immune response and pharmacokinetics. We present a synchrotron-based approach for reducing the minimal detectable marker concentration by demonstrating the feasibility of XFI for measuring the yet inaccessible distribution of the endogenous iodine in murine thyroids under in-vivo conform conditions. This result can be used as a reference case for the design of future preclinical XFI applications as mentioned above. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.